Holdings of CFS Investment Advisory Services, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 305 in 3 countries
- Top ten
- 35.2 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 301 | Globe Life Inc | 1,354 | 205.6K $ | |
| 302 | Monolithic Power Systems Inc | 137 | 201.2K $ | |
| 303 | Esperion Therapeutics Inc | 24,551 | 50.1K $ | |
| 304 | BIOMEA FUSION INC | 15,818 | 35K $ | |
| 305 | Humacyte Inc | 15,000 | 10.7K $ |
Sector breakdown
- Funds 17.5 %
- Technology 4.6 %
- Financials 2.6 %
- Health care 2.6 %
- Industrials 2.1 %
- Consumer staples 1.8 %
- Consumer discretionary 1.0 %
- Utilities 0.8 %
- Communication 0.8 %
- Energy 0.8 %
- Materials 0.7 %
- Unattributed 64.7 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 99.9 %
- Taiwan 0.0 %
- United Kingdom 0.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 303 | 1.3B $ | 99.92 % |
| 2 | Taiwan | 1 | 593.2K $ | 0.05 % |
| 3 | United Kingdom | 1 | 485K $ | 0.04 % |
Cite this page
Titelia. "Holdings of CFS Investment Advisory Services, LLC". https://titelia.com/en/funds/US13F1845688